Find uplifting stories about heroes, innovations, and solutions
71 results for "lung cancer"
Music legend Barry Manilow is recovering from lung cancer surgery that required surgeons to navigate through his vocal cords. Just four months later, he's already working on his comeback with a new album of original songs.
Mount Sinai researchers discovered that focused radiation helps CAR-T therapy work better against tough-to-treat solid tumors like lung cancer and melanoma. The breakthrough could make this life-saving treatment safer and more effective for thousands of cancer patients.
A Greek man with terminal lung cancer moved home to die affordably in 1976. He lived another 37 years, crediting his island's slow-paced lifestyle and Mediterranean diet.
A breakthrough cancer treatment helped patients with advanced lung cancer live over four months longer than current therapies. The experimental drug reduced the risk of death by 34% in a study of 532 patients.
UCLA researchers discovered a targeted therapy drug that dramatically reduces the risk of lung cancer returning in patients with a rare genetic subtype. After two years, 92% of patients receiving the treatment remained cancer-free, compared to just 61% who received a placebo.
A groundbreaking cancer treatment just gave patients with hard-to-treat lung cancer something they desperately needed: hope. Chinese biotech company Akeso's new drug ivonescimab beat the current standard treatment in a major clinical trial, marking a historic win for patients with limited options.
A targeted therapy called selpercatinib dramatically reduces the chance of early-stage lung cancer returning in patients with a rare genetic subtype. After two years, 92% of patients who received the drug remained cancer-free compared to just 61% who got a placebo.
A groundbreaking cancer treatment just showed remarkable results that exceeded doctors' expectations in treating one of the deadliest forms of lung cancer. The drug ivonescimab reduced the risk of death by 34% compared to standard treatment for patients with squamous non-small cell lung cancer.
Over 1,000 survivors, families, and advocates turned a 1-mile zoo walk into a powerful statement of hope, crushing their fundraising goal. The event brought together a community that proves no one has to fight lung cancer alone.
After two years of failed treatments, Philadelphia's Shakirah Duckett found hope in a clinical trial that's finally shrinking her stage 4 lung cancer tumors. Now she's walking at the Lung Force event to celebrate her progress and connect with others facing similar battles.
A lung cancer diagnosis during the pandemic led to an unexpected friendship that changed two lives forever. Michelle Lipchock and her nurse practitioner Lindsay Dougherty prove that healing is about more than medicine.
A Texas mayor, a doctor, and a retired police officer who beat lung cancer are teaming up to save lives through early detection. Their message is simple: screening can catch this silent disease before symptoms even appear.
Researchers are developing blood tests and AI tools that could detect lung cancer in its earliest stages, when survival rates jump from 10% to 90%. These breakthroughs could save thousands of lives each year by making screening faster, safer, and available to more people.
Multiple research teams discovered that aggressive lung cancer cells form actual connections with brain neurons, and drugs that block these connections slow tumor growth in mice. The breakthrough could lead to new treatment options for one of the deadliest cancers.
A New York grandmother is cancer-free after receiving proton therapy, a precise radiation treatment that spared her from typical side effects. Marie Francillion never smoked but developed lung cancer that spread to her lymph nodes in 2022.
A new combination drug therapy reduced lung cancer progression by 65% in a groundbreaking study, offering fresh hope for patients facing this deadly disease. The treatment marks the first successful pairing of two powerful cancer-fighting approaches in previously untreated patients.
A groundbreaking $4 million clinical trial in Canada is pairing gut bacteria capsules with immunotherapy to help lung cancer patients who aren't responding to standard treatments. If successful, the LUNA-2 trial could extend lives and reduce side effects for thousands of Canadians.
Researchers analyzed real-world data from 940 patients to compare five lung cancer drugs, finding clearer answers about which treatments work best. The findings could help doctors and patients make smarter decisions about care.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
Tennessee just became the latest state to require insurance coverage for lifesaving biomarker tests that catch cancer and other diseases early. The new law, championed by a lung cancer survivor, takes effect in January.
Showing 20 of 71